Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan

OBJECTIVE: Cost-benefit is an important consideration for Helicobacter pylori (H. pylori) eradication in Japan, where 1.5 million patients were reported to receive first-line eradication annually. This study aimed to identify the optimal cost-saving triple therapy regimen for H. pylori eradication i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokunaga, Kengo, Suzuki, Chihiro, Hasegawa, Miyuki, Fujimori, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057805/
https://www.ncbi.nlm.nih.gov/pubmed/33889000
http://dx.doi.org/10.2147/CEOR.S297680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057805/
https://www.ncbi.nlm.nih.gov/pubmed/33889000
http://dx.doi.org/10.2147/CEOR.S297680

Ejemplares similares